EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?

Diogo Fernandes Dos Santos, Iago Resende Carvalho iD, Isabella Sabião Borges, Pedro Henrique Sirotheau Corrêa Alves, Fernanda de Oliveira Cirino, Douglas Eulálio Antunes, Raquel Campos Pereira, Marcus Vinicius Magno Gonçalves, Isabela Maria Bernardes Goulart iD

PLOS One · 08.04.2026 · 21 (4) · e0343962

DOI: 10.1371/journal.pone.0343962 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 08.04.2026. Verfasst von Diogo Fernandes Dos Santos und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlâ…. Hauptthemen laut MEDLINE: Demyelinating Diseases, Leprosy, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Leprosy neuropathy (LN) may cause demyelination that worsens during the leprosy reactions (LR). Type-1 LR (T1LR) occurs in patients with cell-mediated immune response against M. leprae, and Type-2 LR (T2LR) occurs in multibacillary cases. The patterns of nerve impairment need to be clarified, as both demyelination and axonal degeneration are commonly observed. This study aimed to describe how to interpret the demyelinating impairment in LN.

Methods

Retrospective observational analysis of leprosy patients in a National Reference Center in Brazil between 2014–2023.

Results

494 participants were included in this study. 3952 nerves were evaluated, with an average of 5.1 (±5.4) nerves affected per patient. 23.5% (116/494) of patients showed a demyelinating pattern defined by standard criteria, and 20.7% (24/116) presented exclusively demyelinating abnormalities without evidence of secondary axonal loss. 81% (94/116) presented conduction block, and 95.7% (111/116) temporal dispersion, with both conditions concomitant in 76.7% (89/116) of patients. 83.6% (97/116) demonstrated prolonged distal motor latency, and 99.1% (115/116) reduction in conduction velocity. 46.1% had T1LR and 17.9% T2LR. The comparison between patients with and without LR showed higher bacillary load, conduction block, and temporal dispersion in LR patients. 93.1% (108/116) of patients fulfilled neurophysiological criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Among them, 46.3% presented clinical criteria for atypical CIDP.

Discussion

Leprosy is a spectral disease in which neural damage can manifest in different phenotypes. Demyelinating impairment is frequent and varies according to the clinical form and presence of LR. Although demyelinating impairment is common in the studied population, it does not reflect active disease. LN can also be misdiagnosed as other peripheral neuropathies, especially CIDP, in non-endemic areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Demyelinating DiseasesLeprosyPeripheral Nervous System DiseasesHumansFemaleMaleMiddle AgedAdultRetrospective StudiesNerve Conduction StudiesBrazilAgedNeural ConductionAdolescentYoung AdultMycobacterium leprae

Autor:innen und Institutionen

  • National Reference Center for Sanitary Dermatology and Leprosy, Clinics' Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, Minas Gerai, Brazil.
  • Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, Minas Gerai, Brazil.
  • Professor of Neurology, School of Medicine, University of the Joinville (UNIVILLE), Joinville, South Carolina, Brazil.

ORCID-Profile: Iago Resende Carvalho, Isabela Maria Bernardes Goulart

Zitieren

APA

Dos Santos, D. F., Carvalho, I. R., Borges, I. S., Alves, P. H. S. C., de Oliveira Cirino, F., Antunes, D. E., Pereira, R. C., Gonçalves, M. V. M., & Bernardes Goulart, I. M. (2026). Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?. PLOS One, 21(4), e0343962. https://doi.org/10.1371/journal.pone.0343962

Vancouver

Dos Santos DF, Carvalho IR, Borges IS, Alves PHSC, de Oliveira Cirino F, Antunes DE, et al. Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?. PLOS One. 2026;21(4):e0343962. doi:10.1371/journal.pone.0343962

BibTeX
@article{DosSantos2026,
  author = {Dos Santos, Diogo Fernandes and Carvalho, Iago Resende and Borges, Isabella Sabião and Alves, Pedro Henrique Sirotheau Corrêa and de Oliveira Cirino, Fernanda and Antunes, Douglas Eulálio and Pereira, Raquel Campos and Gonçalves, Marcus Vinicius Magno and Bernardes Goulart, Isabela Maria},
  title = {Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0343962},
  doi = {10.1371/journal.pone.0343962}
}
Kostenlos starten →